ArticleFrontiers in global women's health2025
Global impact of Occupational Noise-Induced Hearing Loss (ONIHL): trends, gender disparities, and future projections: 1990-2036.
Article in Frontiers in global women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Development and empirical validation of a multi-criteria decision-making model for the assessment of noise-induced hearing loss (NIHL) in high-exposure industrial settings.BMC public health · 2026Article
- Effects of mixed blood metals on hearing loss among steel workers: a case-control study.Frontiers in public health · 2026Article
- Tertiary music students' hearing health behaviors: ignorance is not bliss.Frontiers in psychology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The burden of Occupational Noise-Induced Hearing Loss (ONIHL) is escalating globally, presenting significant challenges to society and healthcare systems. This study aims to provide a comprehensive assessment of the global burden of ONIHL from 1990 to 2021, analyze these impacts by gender, and project the future burden of ONIHL over the next fifteen years. Methods: The data were sourced from the Global Burden of Disease (GBD) study conducted in 2021. A Joinpoint regression model was employed to calculate the annual percentage change (APC) in ONIHL Years Lived with Disability (YLDs) rate, and a decomposition analysis was utilized to quantify the influences of age structure, population growth, and epidemiological changes on the global burden of ONIHL. Additionally, predictions of future YLDs rate trends were made using Bayesian Age-Period-Cohort (BAPC) and Autoregressive Integrated Moving Average (ARIMA) models. Results: The global rate of ONIHL YLDs escalated from 3,838,055 person-years in 1990 to 7,847,445 person-years in 2021, with an age-standardized YLDs rate experiencing a 23% increase. Males exhibited a higher number and rate of YLDs than females, however, the growth rate for females was greater, with Estimated Annual Percentage Changes (EAPCs) recorded at 0.42 (0.41-0.43) for females and 0.11 (0.09-0.12) for males, respectively, and Average Annual Percentage Changes (AAPCs) of 0.44 (95% CI: 0.43-0.45) for females compared to 0.13 (95% CI: 0.12-0.14) for males. In 2021, the YLDs rate decreased as the Socio-Demographic Index (SDI) increased across 224 countries, indicating a concentration of the burden in countries with a medium SDI. Between 1990 and 2021, the incidence of ONIHL among females exhibited an upward trend in most countries, whereas among males, it predominantly reflected a downward trend. The decomposition analysis revealed that population growth was the primary factor contributing to the increase in YLDs. Projections indicate that by 2036, the YLDs rate for ONIHL will reach 103.45 per 100,000 in males and 74.19 per 100,000 in females. Conclusion: The global burden of ONIHL is rising at a concerning rate, particularly in countries with a medium SDI and among females. Therefore, it is imperative to implement targeted health education, regular screenings, and accessible hearing protection measures to mitigate the risks associated with ONIHL, specifically for females.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.